Latest Biotech News

Analysis shows that the U.S. biotech sector is yet to achieve significant growth momentum compared to China’s surging industry performance in 2025. Public market previews and reports from...

The FDA approved three new molecular entities (NMEs) in June 2025, contributing to a year-to-date total of 19 approvals with additional approvals already recorded in July. This steady regulatory...

Industry experts predict a biomanufacturing talent shortage by 2028 due to gaps in existing skills and increased technology demands. Jason Beckwith, PhD, emphasizes the need for cross-industry...

Scripps Research scientists developed a microchip that rapidly maps antibody-virus interactions using minimal blood samples. This innovation provides faster and clearer insights into immune...

Chugai Pharmaceutical, a Roche subsidiary, has partnered with Singapore-based AI company Gero to identify drug targets for age-related diseases using Gero’s human data-centric platform. The...

Johns Hopkins University researchers have expanded the understanding of protein misfolding in age-related cognitive decline beyond amyloid-beta and tau. Using limited proteolysis mass spectrometry...

Univercells Technologies and Repligen have partnered to integrate Repligen’s MAVEN® Real Time Glucose Control Platform into Univercells' scale-X bioreactors. This innovation enables frequent,...

Capricor Therapeutics received an FDA complete response letter (CRL) for deramiocel, its off-the-shelf cell therapy targeting cardiomyopathy in Duchenne muscular dystrophy (DMD). The regulator...

Merck & Co. has finalized the $10 billion acquisition of Verona Pharma, securing the rights to its lead COPD drug, Ohtuvayre. Despite the main patent’s 2020 expiry, Merck is banking on secondary...

Results from the phase 3 Embark trial demonstrate that combining Xtandi with leuprolide significantly improves overall survival in patients with non-metastatic hormone-sensitive prostate cancer...

Microsoft Research AI introduced BioEmu, a generative deep learning system that rapidly emulates protein equilibrium ensembles. Published in Science, BioEmu predicts diverse protein conformations...

Kazakh National Agrarian Research University scientists engineered a monoclonal antibody delivered intranasally that blocks mugwort pollen allergens, preventing hay fever and asthma symptoms in...

Jason Beckwith, PhD from Merrill warns a 'talent singularity' will hit biomanufacturing by 2028, with demand for skilled workers outstripping supply. The sector must adopt cross-industry...

Wacker Chemie launched its Wacker Biotechnology Center, a multi-floor facility focused on biopharmaceutical R&D, including protein and nucleic acid production processes essential for mRNA-based...

Nuclidium AG secured CHF79 million (approximately $99.3 million) in Series B funding to tackle production and supply bottlenecks in radiopharmaceuticals. The capital will support clinical...

Johns Hopkins University researchers have identified over 200 misfolded proteins potentially associated with age-related cognitive decline in rats, suggesting amyloid-beta and tau proteins are not...

Univercells Technologies and Repligen have partnered to integrate real-time monitoring capabilities for glucose and lactate levels in viral vector and vaccine production. The collaboration...

Fecal microbiota transplantation (FMT), initially effective in treating recurrent Clostridioides difficile infections, is attracting research interest for broader applications including alopecia,...

The U.S. FDA issued a Complete Response Letter to Capricor Therapeutics, citing insufficient clinical efficacy data and outstanding chemistry, manufacturing, and controls (CMC) issues for...

Biopharma dealmaking in June 2025 surged to $35.07 billion, the highest monthly total this year and among the strongest in recent history. This boost propelled first-half 2025 deal values to...